What: The Oregon Health Authority’s Retail Marijuana Scientific Advisory Committee is holding its monthly meeting. The meeting is open to the public.Agenda: Review purpose and
Today, Dr. Sue Sisley will lead a clinical lecture on Post-Traumatic Stress Disorder (PTSD) and cannabis as part of the 5th Annual Pain Care Skills
I hate cancer. I know several people that are battling cancer, and it’s painful to watch those strong people go through it. I can’t even
By Paul Armentano, NORML Deputy Director NORML is pleased to present the latest expanded/updated edition of the publication Emerging Clinical Applications for Cannabis & Cannabinoids
I received the following article from Anthony Franciosi, founder of The Honest Marijuana Company out of Colorado, and felt it was worth passing along. Exercising
By Paul Armentano, NORML Deputy Director Two new studies published online today in JAMA (Journal of the American Medical Association) Psychiatry provide little support for
If you ever get a chance to talk to a medical researcher about marijuana, they will be quick to tell you just how hard it
By Paul Armentano, NORML Deputy Director Inhaling cannabis is associated with the remission of refractory idiopathic angioedema, according to a clinical report published in the
Two years ago, TWB published a story I wrote on strains that have been known to help women manage chronic pain stemming from PMS/PMDD. Now
By Paul Armentano, NORML Deputy Director A history of cannabis use is associated with a lower likelihood of obesity and diabetes, according to population-based data
By Allen St. Pierre, NORML Executive Director We read with interest the recent review of medical use of cannabinoids (1). As the authors attempt to
The most widely known cannabinoid is Tetrahydrocannabinol (THC). THC was first ‘discovered’ in 1964 by Israeli scientists Prof. Raphael Mechoulam and Dr. Yechiel Gaoni at
Chronic marijuana use by teenage boys does not appear to be linked to later physical or mental health issues such as depression, psychotic symptoms or
Today, Americans for Safe Access (ASA) is hosting a Congressional Briefing with Representative Earl Blumenauer (D-OR) on federal barriers faced by researchers working to understand
On Thursday, July 23rd Americans for Safe Access (ASA) is hosting a Congressional Briefing with Representative Earl Blumenauer (D-OR) on federal barriers faced by researchers
By Danielle Keane, NORML Political Director Massachusetts Senator Elizabeth Warren, along with seven other Senators, has directed a letter to the Obama administration demanding regulators answer questions specific to the facilitation of research
Less than a week ago a bipartisan amendment was introduced in Congress that would have made it easier to conduct marijuana research. Right now marijuana research
I received the following message from Congressman Sam Farr: Today, Democratic Congressmen Sam Farr (CA-20, and Earl Blumenauer (OR-03), and Republican Congressmen H. Morgan Griffith
I received the following press release from New York University and figured I’d post it for discussion: Marijuana is the most prevalent drug in the
This last week a Congressional drug caucus was held where testimony was provided by Kevin Sabet. As usual, Kevin was ripe with reefer madness. Usually
By Danielle Keane, NORML Political Director Members of the US Senate at a hearing yesterday expressed skepticism in regard to federal policies limiting the ability
Yesterday, the Senate International Narcotics Control Caucus held a hearing on facilitating cannabidiol (CBD) research. CBD is found in cannabis and has shown great potential
At a hearing Wednesday, Sens. Cory Booker and Kirsten Gillibrand pressed federal officials to eliminate political barriers that are preventing research on the potential medical
A very significant victory was achieved today in regards to marijuana research. One of the biggest barriers to research approval was removed. Below are reactions
Subscribe to stay up-to-date with the latest weed news
Subscribe to stay up-to-date with the latest weed news
